98%
921
2 minutes
20
We propose a causal mediation approach to semi-competing risks under left truncation sampling by considering an intermediate event as a mediator and a terminal event as an outcome. We focus on the causal relationship from exposure to the terminal outcome in relation to the intermediate event. In particular, we study the direct effect, the effect of exposure on the terminal event that is not through the intermediate event, and the indirect effect-the effect of exposure on the terminal event that is mediated through the intermediate event. We propose nonparametric and semiparametric methods, both accounting for left truncation. The nonparametric estimator can be viewed as a model-free time-varying Nelson-Aalen estimator that is robust to model misspecification. The semiparametric estimator calculated with the Cox proportional hazards model enjoys flexibility in adjusting for potential confounders as covariates. The asymptotic properties for both estimators, including uniform consistency and weak convergence, were established using the martingale theorem and functional delta method. The finite sample performance of the proposed estimators was evaluated through extensive numerical studies that investigated the influences of left truncation, confounding, and sample size. The utility of the proposed methods was illustrated using a hepatitis study.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/09622802241313291 | DOI Listing |
Background: Sphericity is a measurement of how closely an object approximates a globe. The sphericity of the blood pool of the left ventricle (LV), is an emerging measure linked to myocardial dysfunction.
Methods: Video-based deep learning models were trained for semantic segmentation (pixel labeling) in cardiac magnetic resonance imaging in 84,327 UK Biobank participants.
Commun Stat Theory Methods
February 2025
Division of Biostatistics, Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia 22903.
Statistical methods have been developed for regression modeling of the cumulative incidence function (CIF) given left-truncated right-censored competing risks data. Nevertheless, existing methods typically involve complicated weighted estimating equations or nonparametric conditional likelihood function and often require a restrictive assumption that censoring and/or truncation times are independent of failure time. The pseudo-observation (PO) approach has been used in regression modeling of CIF for right-censored competing risks data under covariate-independent censoring or covariate-dependent censoring.
View Article and Find Full Text PDFEur Heart J
August 2025
Myocardial Homeostasis and Cardiac Injury Programme, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Background: Truncating variants in the Filamin C gene (FLNCtv) are a frequent cause of genetic dilated cardiomyopathy (DCM) and non-dilated left ventricular cardiomyopathy (NDLVC), both characterized by arrhythmic complications and increased risk of sudden cardiac death. Currently, no gene-specific therapies exist for FLNCtv-induced cardiomyopathy. CRISPR activation (CRISPRa), which upregulates gene expression via transcriptional activation without cutting the genome, offers a promising strategy, particularly for genes like FLNC whose large size precludes conventional AAV-based gene replacement.
View Article and Find Full Text PDFOpen Heart
August 2025
Cardiothoracovascular Department, Center for Diagnosis and Treatment of Cardiomyopathies, Azienda Sanitaria Universitaria Giuliano-Isontina, University of Trieste; European Reference Network for Rare, Low-Prevalence, and Complex Diseases of the Heart (ERN GUARD-Heart), Trieste, Italy.
Background: Truncating variants in the Filamin C () gene are causative of highly arrhythmogenic cardiomyopathies. Guidelines remain controversial concerning competitive and high-intensity sports for carriers. Indeed, the impact of high-intensity exercise on individuals carrying these variants remains poorly understood.
View Article and Find Full Text PDFAnn Surg Oncol
August 2025
Department of Breast Surgery, Herlev-Gentofte Hospital, Hellerup, Denmark.
Background: Currently, targeted axillary dissection (TAD) is used in many centers as an alternative to axillary dissection for patients with lymph node metastases at diagnosis who receive neoadjuvant treatment. This allows patients to benefit from an axillary pathologic complete response rate as high as 60% during neoadjuvant treatment. Although the false-negative rate for TAD is low, data on oncologic outcomes are sparse and with limited follow-up time only.
View Article and Find Full Text PDF